PMID- 1922144 OWN - NLM STAT- MEDLINE DCOM- 19911031 LR - 20190702 IS - 0027-5107 (Print) IS - 0027-5107 (Linking) VI - 253 IP - 2 DP - 1991 Oct TI - Inhibition of dinitropyrene mutagenicity in vitro and in vivo using Salmonella typhimurium and the intrasanguinous host-mediated assay. PG - 181-91 AB - Dinitropyrenes (DNP), present in polluted air, are potent direct-acting mutagens in Salmonella typhimurium TA98. This mutagenicity is markedly reduced in the presence of rat-liver S9 or microsomes. This has now been confirmed using mouse hepatic fractions. Since most in vitro test systems do not adequately simulate conditions encountered in the intact animal, we have investigated dinitropyrene mutagenicity to Salmonella in the host-mediated assay. 1,8-Dinitropyrene (1,8-DNP) given p.o. to BALB/c mice induced a weak mutagenic effect in S. typhimurium TA98 recovered from the liver 1 h after i.v. administration (optimum time). Over the entire dose range tested no toxicity to bacterial cells was detected. Mutation induction in vivo was dose-related with maximum response at 1 mg DNP/kg body weight. This optimum dose, however, was non-mutagenic to strains TA98/1,8-DNP6 (O-transacetylase-deficient) or TA98NR/1,8-DNP6 (nitroreductase- and O-transacetylase-deficient). 1,3-Dinitropyrene and 1,6-dinitropyrene were weakly mutagenic to TA98 at doses similar to 1,8-DNP. Studies with [14C]1,8-DNP showed that 1 h after oral dosing (1 mg/kg), over 100 ng of 1,8-DNP equivalents were present in the liver (= 0.73% dose). However, only about 5.5 ng were present in the bacterial pellet, suggesting that hepatic components in vivo, as in vitro, bind to DNP, thus interfering with its interaction with Salmonella. FAU - Shah, A B AU - Shah AB AD - School of Biological Sciences, Portsmouth Polytechnic, Hants, Great Britain. FAU - Rowland, I R AU - Rowland IR FAU - Combes, R D AU - Combes RD LA - eng PT - Journal Article PL - Netherlands TA - Mutat Res JT - Mutation research JID - 0400763 RN - 0 (Mutagens) RN - 0 (Pyrenes) RN - 51U7E9MW6I (1,8-dinitropyrene) RN - 66Q2ZUF83N (1,6-dinitropyrene) RN - D09D9L0924 (1,3-dinitropyrene) SB - IM MH - Administration, Oral MH - Animals MH - Dose-Response Relationship, Drug MH - Female MH - Inactivation, Metabolic MH - Injections, Intravenous MH - Liver/*metabolism MH - Mice MH - Mice, Inbred BALB C MH - Microsomes, Liver/metabolism MH - Mutagenicity Tests/*methods MH - *Mutagens MH - Pyrenes/administration & dosage/pharmacokinetics/*toxicity MH - Salmonella typhimurium/genetics EDAT- 1991/10/01 00:00 MHDA- 1991/10/01 00:01 CRDT- 1991/10/01 00:00 PHST- 1991/10/01 00:00 [pubmed] PHST- 1991/10/01 00:01 [medline] PHST- 1991/10/01 00:00 [entrez] AID - 0165-1161(91)90131-Q [pii] AID - 10.1016/0165-1161(91)90131-q [doi] PST - ppublish SO - Mutat Res. 1991 Oct;253(2):181-91. doi: 10.1016/0165-1161(91)90131-q.